Please complete this 2-minute survey to help us improve our products and services:
Queensland COVID-19 research
This page of Queensland’s research related to the COVID-19 pandemic is compiled from information provided by Queensland universities and research institutes.
While many of our researchers are working on potential vaccines, treatments and other medical interventions, other researchers are applying their expertise to other impacts of the pandemic upon our economy and other aspects of society. The data includes immediate research activity, recent relevant work, proposed research (subject to available funds) and other responses using the resources and expertise of our research organisations.
Listing 1 matching response out of 123 total responses.
Scientists from Menzies Health Institute Queensland and City of Hope in the US have developed an experimental direct-acting antiviral for COVID-19. They used gene-silencing RNA technology - siRNA (small-interfering RNA) to attack the virus's genome directly. This stops the virus from replicating and is delivers the siRNA to the lungs by lipid nanoparticles. This still experimental treatment was designed at Griffith University and City of Hope. The treatment reduces viral load by 99.9% and is designed to work on all betacoronaviruses such as the original SARS virus (SARS-CoV-1) as well as SARS-CoV-2 and any new variants that may arise in the future.
Menzies Health Institute Queensland
- Contact details
Professor Nigel McMillan
Program Director Infectious Diseases and Immunology
+61 0413 730 894
- Collaborator: Beckman Research Institute - City of Hope USA
- Funder: Medical Research Futures Fund - Australian Government
Other Queensland COVID-19 initiatives
- Queensland Government
- Coronavirus (COVID-19) business assistance finder
- Life Sciences Queensland
- Life Sciences Queensland joins the data-powered alliance to stop COVID-19
Key Australian COVID-19 initiatives
Key international COVID-19 initiatives
- CORD-19 (COVID-19 Open Research Dataset)
- Free database of 130,000 plus COVID-19 open research papers